ITC Share Price Live Updates: ITC stock sees a daily rise of 1.08%
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Profit by knowlytics
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
China’s ChangXin Memory Technologies (CXMT) became the country’s most valuable listed company after its shares surged 470% on their Shanghai debut. The blockbuster listing, Asia’s largest IPO this year, highlights strong investor confidence in China’s semiconductor ambitions as Beijing pushes for greater technological self-reliance amid global chip competition.
Wall Street enters its busiest earnings week as Microsoft, Meta, Apple, Amazon, Exxon, Chevron and others report results, with investors watching AI spending, consumer demand, Fed signals and corporate outlooks.
Chinese stocks recovered on Monday after a strong debut by memory chipmaker CXMT Corp. The benchmark CSI300 Index and Shanghai Composite Index saw gains amid investor optimism. CXMT shares surged significantly, briefly making it China’s most valuable listed company. Regulators introduced supportive measures to stabilize markets after recent sharp selloffs. Broader market resilience followed fears…
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Dr Lal PathLabs shares surged after a strong Q1FY27 earnings beat, driven by higher realisations and price hikes. Brokerages including Nomura, Nuvama and JM Financial raised target prices, citing robust growth outlook, network expansion and improving margins, with continued momentum expected from diagnostics demand and strategic investments.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…